Literature DB >> 26501792

Regulatory T Cells Are Critical for Clearing Influenza A Virus in Neonatal Mice.

Samantha Oliphant1,2, J Louise Lines1,2, Melissa L Hollifield1,2, Beth A Garvy1,2,3.   

Abstract

We previously reported that neonatal mice infected with influenza A virus (IAV) develop interstitial pneumonia characterized by reduced lung cytokine and chemokine responses. The failure of T cells to infiltrate the airways of neonates correlated with delayed clearance of sublethal IAV infections compared to adults. We hypothesized that negative regulators in the neonatal lungs such as cytokines or T regulatory (Treg) cells are responsible for these differences. Neonates either deficient in interleukin-10 (IL-10) or with T cells unresponsive to transforming growth factor-β signaling due to absence of SMAD family member 4 (Smad4) had similar IAV clearance kinetics to wild-type pups and no difference in T-cell responses. In contrast, functional depletion of Treg cells with anti-CD25 monoclonal antibody resulted in increased proportions of activated CD4(+) T cells in the lungs, but failure to clear IAV. Similarly, scurfy pups (mutation in forkhead box P3 [Foxp3] rendering them deficient in Treg cells) had increased proportions of activated T cells in the lungs compared to littermate controls. Scurfy pups also had increased proportions of IL-13-producing CD4(+) T cells. Interestingly, like anti-CD25-treated pups, scurfy pups had significantly elevated viral loads compared to controls. Based on these data, we conclude that Tregs are critical for clearance of IAV in neonatal mice.

Entities:  

Mesh:

Year:  2015        PMID: 26501792      PMCID: PMC4677544          DOI: 10.1089/vim.2015.0039

Source DB:  PubMed          Journal:  Viral Immunol        ISSN: 0882-8245            Impact factor:   2.257


  47 in total

1.  Neonatal lung immune responses show a shift of cytokines and transcription factors toward Th2 and a deficit in conventional and plasmacytoid dendritic cells.

Authors:  Xavier Roux; Aude Remot; Agnès Petit-Camurdan; Marie-Anne Nahori; Hélène Kiefer-Biasizzo; Gilles Marchal; Micheline Lagranderie; Sabine Riffault
Journal:  Eur J Immunol       Date:  2011-08-30       Impact factor: 5.532

2.  X-linked lymphoreticular disease in the scurfy (sf) mutant mouse.

Authors:  V L Godfrey; J E Wilkinson; L B Russell
Journal:  Am J Pathol       Date:  1991-06       Impact factor: 4.307

3.  A detrimental effect of interleukin-10 on protective pulmonary humoral immunity during primary influenza A virus infection.

Authors:  Keer Sun; Luisa Torres; Dennis W Metzger
Journal:  J Virol       Date:  2010-03-03       Impact factor: 5.103

4.  Cutting Edge: Anti-CD25 monoclonal antibody injection results in the functional inactivation, not depletion, of CD4+CD25+ T regulatory cells.

Authors:  Adam P Kohm; Jeffrey S McMahon; Joseph R Podojil; Wendy Smith Begolka; Mathew DeGutes; Deborah J Kasprowicz; Steven F Ziegler; Stephen D Miller
Journal:  J Immunol       Date:  2006-03-15       Impact factor: 5.422

Review 5.  Transforming growth factor-beta regulation of immune responses.

Authors:  Ming O Li; Yisong Y Wan; Shomyseh Sanjabi; Anna-Karin L Robertson; Richard A Flavell
Journal:  Annu Rev Immunol       Date:  2006       Impact factor: 28.527

6.  Type beta transforming growth factor is the primary differentiation-inducing serum factor for normal human bronchial epithelial cells.

Authors:  T Masui; L M Wakefield; J F Lechner; M A LaVeck; M B Sporn; C C Harris
Journal:  Proc Natl Acad Sci U S A       Date:  1986-04       Impact factor: 11.205

7.  Coordination of early protective immunity to viral infection by regulatory T cells.

Authors:  Jennifer M Lund; Lianne Hsing; Thuy T Pham; Alexander Y Rudensky
Journal:  Science       Date:  2008-04-24       Impact factor: 47.728

8.  Neonatal CD8 T-cell hierarchy is distinct from adults and is influenced by intrinsic T cell properties in respiratory syncytial virus infected mice.

Authors:  Tracy J Ruckwardt; Allison M W Malloy; Emma Gostick; David A Price; Pradyot Dash; Jennifer L McClaren; Paul G Thomas; Barney S Graham
Journal:  PLoS Pathog       Date:  2011-12-01       Impact factor: 6.823

9.  FoxP3+ regulatory T cells promote influenza-specific Tfh responses by controlling IL-2 availability.

Authors:  Beatriz León; John E Bradley; Frances E Lund; Troy D Randall; André Ballesteros-Tato
Journal:  Nat Commun       Date:  2014-03-17       Impact factor: 14.919

10.  Influence of CD8+ T regulatory cells on intraocular tumor development.

Authors:  Kyle C McKenna; Dana M Previte
Journal:  Front Immunol       Date:  2012-09-28       Impact factor: 7.561

View more
  11 in total

1.  CD4+ Regulatory T Cells Exert Differential Functions during Early and Late Stages of the Immune Response to Respiratory Viruses.

Authors:  Meredith C Rogers; Kristina D Lamens; Nazly Shafagati; Monika Johnson; Tim D Oury; Sebastian Joyce; John V Williams
Journal:  J Immunol       Date:  2018-07-11       Impact factor: 5.422

Review 2.  Age-Dependent Differences in T-Cell Responses to Influenza A Virus.

Authors:  Andrew D Prigge; Ruihua Ma; Bria M Coates; Benjamin D Singer; Karen M Ridge
Journal:  Am J Respir Cell Mol Biol       Date:  2020-10       Impact factor: 6.914

3.  Contribution of Regulatory T Cells in Nucleotide-Binding Oligomerization Domain 2 Response to Influenza Virus Infection.

Authors:  Benoit Egarnes; Jean Gosselin
Journal:  Front Immunol       Date:  2018-01-31       Impact factor: 7.561

4.  Regulatory T cell frequencies and phenotypes following anti-viral vaccination.

Authors:  A Charlotte M T de Wolf; Susan van Aalst; Irene S Ludwig; Caroline L Bodinham; David J Lewis; Ruurd van der Zee; Willem van Eden; Femke Broere
Journal:  PLoS One       Date:  2017-06-28       Impact factor: 3.240

Review 5.  Rationale for the clinical use of adipose-derived mesenchymal stem cells for COVID-19 patients.

Authors:  Christopher J Rogers; Robert J Harman; Bruce A Bunnell; Martin A Schreiber; Charlie Xiang; Fu-Sheng Wang; Antonio F Santidrian; Boris R Minev
Journal:  J Transl Med       Date:  2020-05-18       Impact factor: 5.531

Review 6.  Challenges for the Newborn Immune Response to Respiratory Virus Infection and Vaccination.

Authors:  Kali F Crofts; Martha A Alexander-Miller
Journal:  Vaccines (Basel)       Date:  2020-09-24

7.  Mesenchymal stem cell-derived extracellular vesicles attenuate influenza virus-induced acute lung injury in a pig model.

Authors:  Mahesh Khatri; Levi Arthur Richardson; Tea Meulia
Journal:  Stem Cell Res Ther       Date:  2018-01-29       Impact factor: 6.832

Review 8.  Stem cells or their exosomes: which is preferred in COVID-19 treatment?

Authors:  Nashmin Fayazi Hosseini; Razieh Dalirfardouei; Mohammad Reza Aliramaei; Rezvan Najafi
Journal:  Biotechnol Lett       Date:  2022-01-19       Impact factor: 2.716

9.  Protection against neonatal respiratory viral infection via maternal treatment during pregnancy with the benign immune training agent OM-85.

Authors:  Jean-Francois Lauzon-Joset; Kyle T Mincham; Naomi M Scott; Yasmine Khandan; Philip A Stumbles; Patrick G Holt; Deborah H Strickland
Journal:  Clin Transl Immunology       Date:  2021-07-01

Review 10.  Multipotent Stromal Cells and Viral Interaction: Current Implications for Therapy.

Authors:  Nopmanee Taechangam; Amir Kol; Boaz Arzi; Dori L Borjesson
Journal:  Stem Cell Rev Rep       Date:  2021-08-04       Impact factor: 5.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.